Cardiology

Study finds racial inequality within heart transplant process

A new study from the University of Missouri found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device, or LVAD, later in their disease progression compared to white ...

Medications

Terlipressin bests placebo in type 1 hepatorenal syndrome

(HealthDay)—For patients with type 1 hepatorenal syndrome (HRS-1), terlipressin is more effective than placebo for reversal of HRS, according to a study published in the March 4 issue of the New England Journal of Medicine.

page 1 from 40